We've found
3,769
archived clinical trials in
Migraine Headaches
We've found
3,769
archived clinical trials in
Migraine Headaches
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
Updated: 12/10/2015
A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache
Status: Enrolling
Updated: 12/10/2015
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
Updated: 12/10/2015
A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache
Status: Enrolling
Updated: 12/10/2015
Click here to add this to my saved trials
Statin/Vitamin D & Migraine Study
Updated: 12/17/2015
Combined Statin and Vitamin D Therapy for Prophylactic Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/17/2015
Statin/Vitamin D & Migraine Study
Updated: 12/17/2015
Combined Statin and Vitamin D Therapy for Prophylactic Treatment of Episodic Migraine
Status: Enrolling
Updated: 12/17/2015
Click here to add this to my saved trials
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
Updated: 12/17/2015
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine (The KSPN Migraine Study)
Status: Enrolling
Updated: 12/17/2015
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine
Updated: 12/17/2015
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine (The KSPN Migraine Study)
Status: Enrolling
Updated: 12/17/2015
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Safety, Efficacy and Pharmacokinetics of ALD403
Updated: 1/6/2016
A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 1b Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of a Single Dose of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 1/6/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Status: Enrolling
Updated: 1/11/2016
Updated: 1/11/2016
Click here to add this to my saved trials